Closing Bell: Hls Therapeutics Inc up on Wednesday (HLS)

Hls Therapeutics Inc opened trading today at $3.13 and closed at $3.27. It traded at a low of $3.13 to a high of $3.27.

Shares advanced 0.31 percent from the previous day's close of $3.26.

During the day across North America, the TSX Composite closed 1.25% at 23110.81, the S&P 500 closed -0.50% at 5436.44, the Dow Jones Industrial Average closed 0.50% at 40743.33 and the Nasdaq Composite closed -1.28% at 17147.42.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

A total of 2,403 shares was traded during the session, with total trades of 8, with an average volume of 97,804 over the last 5 days.

Trading across the entire TSX saw 3,418 price advancers against 1,773 declines and 138 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.30 (August 01,2023) and low as $3.07 (July 24,2024). Moreover, the shares have shrunken -47.09 percent in the last year, while they have eased -17.22% this year.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $103.72 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Currently, Hls Therapeutics Inc has an average recommendation of "Moderate Buy" based on 5.00 analysts according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..